These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3805529

  • 41. Values and limitations of programmed stimulation and ambulatory monitoring in the management of ventricular tachycardia.
    Kim SG.
    Am J Cardiol; 1988 Nov 03; 62(14):7I-12I. PubMed ID: 2461072
    [Abstract] [Full Text] [Related]

  • 42. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA.
    Am J Cardiol; 1996 Aug 29; 78(4A):34-40. PubMed ID: 8780327
    [Abstract] [Full Text] [Related]

  • 43. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
    Mitchell LB, Duff HJ, Manyari DE, Wyse DG.
    N Engl J Med; 1987 Dec 31; 317(27):1681-7. PubMed ID: 3320747
    [Abstract] [Full Text] [Related]

  • 44. Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation.
    Gradman AH, Batsford WP, Rieur EC, Leon L, Van Zetta AM.
    J Am Coll Cardiol; 1985 May 31; 5(5):1087-93. PubMed ID: 3989118
    [Abstract] [Full Text] [Related]

  • 45. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L, Kadish A, Morady F.
    Circulation; 1991 Jul 31; 84(1):101-8. PubMed ID: 1905591
    [Abstract] [Full Text] [Related]

  • 46. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN.
    J Am Coll Cardiol; 1985 Oct 31; 6(4):814-21. PubMed ID: 3928727
    [Abstract] [Full Text] [Related]

  • 47. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M.
    Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121
    [Abstract] [Full Text] [Related]

  • 48. The prognostic value of the changes in the mode of ventricular tachycardia induction noted during therapy with a marked reduction of ventricular ectopic activity.
    Kim SG, Felder SD, Seiden SW, Waspe LE, Fisher JD.
    Am Heart J; 1987 Nov 15; 114(5):1138-45. PubMed ID: 3673880
    [Abstract] [Full Text] [Related]

  • 49. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ.
    Heart; 1998 Apr 15; 79(4):331-6. PubMed ID: 9616338
    [Abstract] [Full Text] [Related]

  • 50. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan 15; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 51. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
    Kalbfleisch SJ, Williamson B, Man KC, Vorperian V, Hummel JD, Hasse C, Strickberger SA, Calkins H, Langberg JJ, Morady F.
    J Am Coll Cardiol; 1993 Nov 15; 22(6):1723-9. PubMed ID: 8227846
    [Abstract] [Full Text] [Related]

  • 52. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M, Milei J, Piñeiro DJ, Buceta JE, Dreyer MP.
    Acta Cardiol; 1983 Nov 15; 38(2):125-32. PubMed ID: 6603085
    [Abstract] [Full Text] [Related]

  • 53. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME.
    Circulation; 1984 Sep 15; 70(3):451-6. PubMed ID: 6744550
    [Abstract] [Full Text] [Related]

  • 54. Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
    Nasir N, Doyle TK, Wheeler SH, Pacifico A.
    Am J Cardiol; 1994 Mar 15; 73(8):554-8. PubMed ID: 7511872
    [Abstract] [Full Text] [Related]

  • 55. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME.
    Circulation; 1986 Nov 15; 74(5):1037-43. PubMed ID: 3769163
    [Abstract] [Full Text] [Related]

  • 56. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR.
    Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883
    [Abstract] [Full Text] [Related]

  • 57. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F, Scheinman MM, Hess DS.
    Pacing Clin Electrophysiol; 1983 May 01; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [Abstract] [Full Text] [Related]

  • 58. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M, Breithardt G.
    Z Kardiol; 1986 Feb 01; 75(2):70-9. PubMed ID: 3705680
    [Abstract] [Full Text] [Related]

  • 59. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M, Eggeling T, Hombach V.
    Eur Heart J; 1993 Sep 01; 14 Suppl E():107-19. PubMed ID: 8223747
    [Abstract] [Full Text] [Related]

  • 60. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
    Fananapazir L, Leon MB, Bonow RO, Tracy CM, Cannon RO, Epstein SE.
    Am J Cardiol; 1991 Jan 15; 67(2):169-74. PubMed ID: 1987718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.